Kathleen M. Murphy

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia

B. Douglas Smith, Mark J. Levis, Miloslav Beran et al. · Blood · 2004 · 629 citations

Medicine, Oncology, Pharmacology +11

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Kathleen M. Murphy, Kieran Brune, Constance A. Griffin et al. · PubMed · 2002 · 443 citations

Medicine, Genetics, Oncology +14

Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice

Jean‐Emmanuel Sarry, Kathleen M. Murphy, Robin Perry et al. · Journal of Clinical Investigation · 2010 · 383 citations

Medicine, Cell Biology, Oncology +16

Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells

Kathleen M. Murphy, Velvizhi Ranganathan, M L Farnsworth et al. · Cell Death and Differentiation · 2000 · 358 citations

Life Sciences, Cell Biology, Pharmacology +16

Detection of Tumor <i>PIK3CA</i> Status in Metastatic Breast Cancer Using Peripheral Blood

Michaela J. Higgins, Danijela Jelovac, Evan Barnathan et al. · Clinical Cancer Research · 2012 · 308 citations · Full text

Medicine, Molecular Biology, Oncology +17